208 related articles for article (PubMed ID: 12621480)
1. Central nervous system aspergillosis in allogeneic stem cell transplant recipients.
Jantunen E; Volin L; Salonen O; Piilonen A; Parkkali T; Anttila VJ; Paetau A; Ruutu T
Bone Marrow Transplant; 2003 Feb; 31(3):191-6. PubMed ID: 12621480
[TBL] [Abstract][Full Text] [Related]
2. Aspergillosis of the central nervous system: a catastrophic opportunistic infection.
Pongbhaesaj P; Dejthevaporn C; Tunlayadechanont S; Witoonpanich R; Sungkanuparph S; Vibhagool A
Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):119-25. PubMed ID: 15272754
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients.
Jantunen E; Piilonen A; Volin L; Parkkali T; Koukila-Kähkölä P; Ruutu T; Ruutu P
Bone Marrow Transplant; 2000 Apr; 25(8):867-71. PubMed ID: 10808208
[TBL] [Abstract][Full Text] [Related]
4. Low incidence of invasive aspergillosis in allogeneic stem cell transplant recipients receiving amphotericin B inhalation prophylaxis.
Nihtinen A; Anttila VJ; Ruutu T; Juvonen E; Volin L
Transpl Infect Dis; 2012 Feb; 14(1):24-32. PubMed ID: 21749589
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
Mikulska M; Raiola AM; Bruno B; Furfaro E; Van Lint MT; Bregante S; Ibatici A; Del Bono V; Bacigalupo A; Viscoli C
Bone Marrow Transplant; 2009 Sep; 44(6):361-70. PubMed ID: 19308042
[TBL] [Abstract][Full Text] [Related]
6. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
[TBL] [Abstract][Full Text] [Related]
7. Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors.
Subirà M; Martino R; Franquet T; Puzo C; Altés A; Sureda A; Brunet S; Sierra J
Haematologica; 2002 May; 87(5):528-34. PubMed ID: 12010668
[TBL] [Abstract][Full Text] [Related]
8. Radiologically guided fine needle lung biopsies in the evaluation of focal pulmonary lesions in allogeneic stem cell transplant recipients.
Jantunen E; Piilonen A; Volin L; Ruutu P; Parkkali T; Koukila-Kähkölä P; Ruutu T
Bone Marrow Transplant; 2002 Feb; 29(4):353-6. PubMed ID: 11896433
[TBL] [Abstract][Full Text] [Related]
9. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients.
Post MJ; Lass-Floerl C; Gastl G; Nachbaur D
Transpl Infect Dis; 2007 Sep; 9(3):189-95. PubMed ID: 17511828
[TBL] [Abstract][Full Text] [Related]
10. Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening.
Hebart H; Löffler J; Meisner C; Serey F; Schmidt D; Böhme A; Martin H; Engel A; Bunje D; Kern WV; Schumacher U; Kanz L; Einsele H
J Infect Dis; 2000 May; 181(5):1713-9. PubMed ID: 10823773
[TBL] [Abstract][Full Text] [Related]
11. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients.
Maertens J; Van Eldere J; Verhaegen J; Verbeken E; Verschakelen J; Boogaerts M
J Infect Dis; 2002 Nov; 186(9):1297-306. PubMed ID: 12402199
[TBL] [Abstract][Full Text] [Related]
12. Parainfluenza type 3 infection post stem cell transplant: high prevalence but low mortality.
Dignan F; Alvares C; Riley U; Ethell M; Cunningham D; Treleaven J; Ashley S; Bendig J; Morgan G; Potter M
J Hosp Infect; 2006 Aug; 63(4):452-8. PubMed ID: 16772104
[TBL] [Abstract][Full Text] [Related]
13. Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders.
Hovi L; Saxen H; Saarinen-Pihkala UM; Vettenranta K; Meri T; Richardson M
Pediatr Blood Cancer; 2007 Jan; 48(1):28-34. PubMed ID: 16395687
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic stem cell transplantation in children with acute lymphoblastic leukemia after isolated central nervous system relapse: our experiences and review of the literature.
Yoshihara T; Morimoto A; Kuroda H; Imamura T; Ishida H; Tsunamoto K; Naya M; Hibi S; Todo S; Imashuku S
Bone Marrow Transplant; 2006 Jan; 37(1):25-31. PubMed ID: 16247416
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of sequential Aspergillus galactomannan antigen detection combined with early radiologic evaluation for diagnosis of invasive pulmonary aspergillosis in patients undergoing allogeneic stem cell transplantation.
Busca A; Locatelli F; Barbui A; Limerutti G; Serra R; Libertucci D; Falda M
Transplant Proc; 2006 Jun; 38(5):1610-3. PubMed ID: 16797366
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA).
Ito JI; Chandrasekar PH; Hooshmand-Rad R
Bone Marrow Transplant; 2005 Nov; 36(10):873-7. PubMed ID: 16113663
[TBL] [Abstract][Full Text] [Related]
17. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F
Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077
[TBL] [Abstract][Full Text] [Related]
18. Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress?
Jantunen E; Anttila VJ; Ruutu T
Bone Marrow Transplant; 2002 Dec; 30(12):925-9. PubMed ID: 12476286
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance.
Siegal D; Keller A; Xu W; Bhuta S; Kim DH; Kuruvilla J; Lipton JH; Messner H; Gupta V
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1369-79. PubMed ID: 17950923
[TBL] [Abstract][Full Text] [Related]
20. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
